Literature DB >> 14695815

Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase.

Vincenzo Summa1, Alessia Petrocchi, Paola Pace, Victor G Matassa, Raffaele De Francesco, Sergio Altamura, Licia Tomei, Uwe Koch, Philippe Neuner.   

Abstract

alpha,gamma-Diketo acids (DKA) were discovered from screening as selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase. The diketo acid moiety proved essential for activity, while substitution on the gamma position was necessary for selectivity and potency. Optimization led to the identification of a DKA inhibitor of NS5b polymerase with IC(50) = 45 nM, one of the most potent HCV NS5b polymerase inhibitors reported.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695815     DOI: 10.1021/jm0342109

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.

Authors:  Anita Y M Howe; Huiming Cheng; Ian Thompson; Srinivas K Chunduru; Steve Herrmann; John O'Connell; Atul Agarwal; Rajiv Chopra; Alfred M Del Vecchio
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors.

Authors:  Jan Paeshuyse; Inge Vliegen; Lotte Coelmont; Pieter Leyssen; Oriana Tabarrini; Piet Herdewijn; Harald Mittendorfer; Johnny Easmon; Violetta Cecchetti; Ralf Bartenschlager; Gerhard Puerstinger; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

3.  Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.

Authors:  Joël Didierjean; Catherine Isel; Flore Querré; Jean-François Mouscadet; Anne-Marie Aubertin; Jean-Yves Valnot; Serge R Piettre; Roland Marquet
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.

Authors:  Hongmei Mo; Liangjun Lu; Tami Pilot-Matias; Ron Pithawalla; Rubina Mondal; Sherie Masse; Tatyana Dekhtyar; Teresa Ng; Gennadiy Koev; Vincent Stoll; Kent D Stewart; John Pratt; Pam Donner; Todd Rockway; Clarence Maring; Akhteruzzaman Molla
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.

Authors:  Kyung-Soo Chang; Zhaohui Cai; Chen Zhang; Ganes C Sen; Bryan R G Williams; Guangxiang Luo
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.

Authors:  Hong-Tao Xu; Susan P Colby-Germinario; Said Hassounah; Peter K Quashie; Yingshan Han; Maureen Oliveira; Brent R Stranix; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

7.  A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

Authors:  Daria J Hazuda; Neville J Anthony; Robert P Gomez; Samson M Jolly; John S Wai; Linghang Zhuang; Thorsten E Fisher; Mark Embrey; James P Guare; Melissa S Egbertson; Joseph P Vacca; Joel R Huff; Peter J Felock; Marc V Witmer; Kara A Stillmock; Robert Danovich; Jay Grobler; Michael D Miller; Amy S Espeseth; Lixia Jin; I-Wu Chen; Jiunn H Lin; Kelem Kassahun; Joan D Ellis; Bradley K Wong; Wei Xu; Paul G Pearson; William A Schleif; Riccardo Cortese; Emilio Emini; Vincenzo Summa; M Katharine Holloway; Steven D Young
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

8.  A novel strategy to assemble the beta-diketo acid pharmacophore of HIV integrase inhibitors on purine nucleobase scaffolds.

Authors:  Vinod Uchil; Byung Seo; Vasu Nair
Journal:  J Org Chem       Date:  2007-10-05       Impact factor: 4.354

9.  Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.

Authors:  Aaditya Bhatt; K R Gurukumar; Amartya Basu; Maulik R Patel; Neerja Kaushik-Basu; Tanaji T Talele
Journal:  Eur J Med Chem       Date:  2011-08-26       Impact factor: 6.514

10.  Mechanism of hepatitis C virus RNA polymerase inhibition with dihydroxypyrimidines.

Authors:  Megan H Powdrill; Jerome Deval; Frank Narjes; Raffaele De Francesco; Matthias Götte
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.